???global.info.a_carregar???
Identification

Personal identification

Full name
Rui Pedro Lourenço Teixeira

Citation names

  • Teixeira, RL

Author identifiers

Ciência ID
6010-D535-75A2
ORCID iD
0000-0001-7324-4522

Knowledge fields

  • Medical and Health Sciences - Clinical Medicine - Rheumatology
  • Medical and Health Sciences - Basic Medicine - Immunology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese Proficiency (C2) Proficiency (C2) Proficiency (C2) Proficiency (C2)
English Upper intermediate (B2) Advanced (C1) Advanced (C1) Upper intermediate (B2)
French Beginner (A1) Intermediate (B1) Elementary (A2) Intermediate (B1)
Galician Elementary (A2) Intermediate (B1) Elementary (A2) Intermediate (B1)
Catalan Beginner (A1) Elementary (A2) Beginner (A1) Elementary (A2)
Italian Elementary (A2) Intermediate (B1) Elementary (A2) Intermediate (B1)
Education
Degree Classification
2023
Ongoing
 Medicina (Doutoramento)
Major in Especialidade: Reumatologia
Universidade de Lisboa Faculdade de Medicina, Portugal
"The role of Jak-Stat signalling pathway as key to chronic artritis onset" (THESIS/DISSERTATION)
2011
Concluded
 Mestrado Integrado em Medicina (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
"The role of matrix metalloproteinase-1 in cancer metastasis" (THESIS/DISSERTATION)
 16
Affiliation

Science

Category
Host institution 		Employer
2013/01/02 - 2018 Researcher (Research) Instituto de Medicina Molecular, Portugal

Teaching in Higher Education

Category
Host institution 		Employer
2011/09/01 - Current Assistant (University Teacher) Universidade de Lisboa Faculdade de Medicina, Portugal

Other Careers

Category
Host institution 		Employer
2013/01/02 - Current Interno (Médica) Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2012/01/02 - 2012/12/31 Interno (Médica) Centro Hospitalar de Setubal EPE, Portugal

Others

Category
Host institution 		Employer
2015/01/15 - Current Investigator in clinical trials Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
Outputs

Publications

Journal article
  1. "Portuguese recommendations for the use of biological and targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis – 2020 update". ARP Rheumatology 1 1 (2021): 63-82. https://www.arprheumatology.com/article_abstract.php?id=1393.
    Open access • Accepted
  2. "A COVID-19 Outbreak in a Rheumatology Department Upon the Early Days of the Pandemic". Front Med (Lausanne) 7 (2020): 576162. https://pubmed.ncbi.nlm.nih.gov/33102507/.
    Open access • Accepted
  3. Teixeira, Rui. "Portuguese recommendations for the use of ultrasound in rheumatology.". Acta Reumatologica Portuguesa 44 1 (2019): 7-28.
    Published
  4. Teixeira, Rui. "Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe.". RMD Open (2018): https://europepmc.org/articles/PMC6241983.
    10.1136/rmdopen-2018-000799
  5. Cascão, Rita; Vidal, Bruno; Jalmari Finnilä, Mikko Arttu; Lopes, Inês Pascoal; Teixeira, Rui Lourenço; Saarakkala, Simo; Moita, Luis Ferreira; Fonseca, João Eurico. "Effect of celastrol on bone structure and mechanics in arthritic rats". (2017): http://hdl.handle.net/10400.7/790.
    10.1136/rmdopen-2017-000438
  6. Teixeira, Rui. "RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro.". PloS One (2013): https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23696795/?tool=EBI.
    10.1371/journal.pone.0063153